Want to see LFST full AI Analyst Report?
LFST Stock Chart & Stats
$6.89
$0.15(1.99%)
At close: 4:00 PM EST
$6.89
$0.15(1.99%)
Day’s Range― - ―
52-Week Range$3.74 - $11.68
Previous CloseN/A
Volume196.56K
Average Volume (3M)3.84M
Market Cap
$4.49B
Enterprise Value$2.80K
Total Cash (Recent Filing)$194.80M
Total Debt (Recent Filing)$196.19M
Price to Earnings (P/E)192.4
Beta0.53
Next Earnings
Aug 06, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding387,834,440
10 Day Avg. Volume3,688,369
30 Day Avg. Volume3,843,327
Financial Highlights & Ratios
PEG Ratio-1.96
Price to Book (P/B)1.79
Price to Sales (P/S)1.91
P/FCF Ratio24.70
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$11.50Price Target Upside66.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)0.13
Revenue Forecast (FY)$1.66B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationSizable and growing free cash flow (TTM FCF $178.8M, +22.3% growth) provides durable internal funding for organic expansion, technology investments, tuck‑ins, and buybacks without heavy reliance on debt. Strong cash conversion supports multi‑year margin and capital allocation flexibility.
Visit Volume And Clinician Productivity GainsSustained volume growth and higher visits per clinician expand capacity utilization and scale economics. A growing clinician network (8,349 clinicians) plus productivity gains underpin repeatable revenue growth and operational leverage that should persist as the outpatient behavioral health market expands.
Improving Margins With Conservative LeverageMeaningful adjusted EBITDA expansion and raised guidance, combined with low leverage metrics (debt/equity ~0.13, net leverage ~0.5x), indicate improved profitability and financial flexibility. This mix supports reinvestment and risk tolerance for multi‑year initiatives while limiting solvency risk.
Bears Say
Limited Revenue-per-visit Growth (TRPV)Modest TRPV expansion constrains sustainable margin upside because price/reimbursement per encounter is growing slowly. Over time, limited per‑visit revenue growth increases reliance on volume and productivity to drive earnings, exposing results to utilization cycles and reimbursement pressure.
Multi-year EHR Transition Execution RiskA large, multi‑year enterprise EHR rollout introduces execution, integration, and productivity risk that can disrupt scheduling, billing and clinician workflows. Extended IT projects can raise costs and temporarily depress margins, making near‑term efficiency gains less certain over the transition window.
Clinician Retention Shows No Measurable ImprovementStable clinician churn despite productivity efforts signals ongoing workforce risk; recruiting and retaining clinicians is critical to capacity and revenue. Persistent retention weakness can raise hiring costs, limit geographic expansion, and cap visit growth over multiple quarters.
Lifestance Health Group News
LFST FAQ
What was Lifestance Health Group, Inc.’s price range in the past 12 months?
Lifestance Health Group, Inc. lowest stock price was $3.74 and its highest was $11.68 in the past 12 months.
What is Lifestance Health Group, Inc.’s market cap?
Lifestance Health Group, Inc.’s market cap is $4.49B.
When is Lifestance Health Group, Inc.’s upcoming earnings report date?
Lifestance Health Group, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 17 days.
How were Lifestance Health Group, Inc.’s earnings last quarter?
Lifestance Health Group, Inc. released its earnings results on May 07, 2026. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.007 by $0.033.
Is Lifestance Health Group, Inc. overvalued?
According to Wall Street analysts Lifestance Health Group, Inc.’s price is currently Undervalued.
Does Lifestance Health Group, Inc. pay dividends?
Lifestance Health Group, Inc. does not currently pay dividends.
What is Lifestance Health Group, Inc.’s EPS estimate?
Lifestance Health Group, Inc.’s EPS estimate is 0.03.
How many shares outstanding does Lifestance Health Group, Inc. have?
Lifestance Health Group, Inc. has 387,834,440 shares outstanding.
What happened to Lifestance Health Group, Inc.’s price movement after its last earnings report?
Lifestance Health Group, Inc. reported an EPS of $0.04 in its last earnings report, beating expectations of $0.007. Following the earnings report the stock price went up 20.245%.
Which hedge fund is a major shareholder of Lifestance Health Group, Inc.?
Currently, no hedge funds are holding shares in LFST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lifestance Health Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.50 (66.91% Upside)
$11.50 (66.91% Upside)
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $290.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 10.1%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
161.99%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.96%
Trailing 12-Months
Company Description
Lifestance Health Group, Inc.
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
LFST Stock 12 Month Forecast
Average Price Target
$11.50
▲(66.91% Upside)
Technical Analysis
Acadia Healthcare
―
Brookdale Senior Living
―
National Healthcare
―
―
Aveanna Healthcare Holdings
―
Ownership Overview
50.54% Insiders
21.27% Mutual Funds
0.07% Other Institutional Investors
13.10% Public Companies and
Individual Investors